Company profile
Jade Therapeutics company profile
Jade Therapeutics develops ophthalmic sustained-release drug delivery platforms. The company focuses on the development of locally administered, sustained-release therapeutics that improve corneal healing following damage from disease or injury and improve visual function and quality of life. Its product delivers recombinant human growth hormone, a well-characterized biologic, that has healing properties via the activation and recruitment of key cells involved in the tissue-building process.
Business identity
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2011-01-01, Year
Headquarters
- Headquarters
- Waltham, Massachusetts, United States
- Postal code
- 02452
- Country code
- US
- Continent
- North America